Category Archives: Vaccines

MSF Challenges Pfizer’s Monopoly on Lifesaving Pneumonia Vaccine in Korea

Doctors Without Borders urges Pfizer to drop unmerited patents that hinder access to lifesaving childhood vaccine worldwide  NEW YORK/SEOUL, FEBRUARY 6, 2018—The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is in the process of submitting a legal … Continue reading

Posted in Patent, Patent Opposition, Uncategorized, Vaccines | Leave a comment

WHO on MSF patent challenge: a win in India could save lives

MSF’s unprecedented legal challenge of the patent on Pfizer’s pneumonia vaccine Prevenar 13 in India is a “rational … coherent” strategy which, if successful, could save lives by opening the way for cheaper vaccines, a WHO vaccine expert tells Development Today. The … Continue reading

Posted in Patent, Patent Opposition, Uncategorized, Vaccines | Leave a comment

Doctors Without Borders contests Pfizer’s patent on pneumonia vaccine

Pfizer has come under fire for holding exclusive patent rights that bars competition on its pneumonia vaccine worldwide, which is being challenged in patent litigations in several countries, an aid group said Monday. Doctors Without Borders will challenge Pfizer in … Continue reading

Posted in Patent, Patent examination system, Patent Opposition, Uncategorized, Vaccines | Leave a comment

Pfizer patent for pneumonia drug could have a deadly impact on public health

India carries the world’s highest burden of pneumonia and accounts for nearly 20% of global infant pneumonia deaths Opinion piece: Leena Menghaney, The Hindustan Times India’s Patent Office has dealt a major setback to hopes for improved access to an … Continue reading

Posted in Indian Patent Law, Indian Patent Office, Patent, Patent Opposition, Uncategorized, Vaccines | Leave a comment

Dangerous pneumonia on the loose, but affordable vaccine to get tough to procure; uproar sparked off; reason will SHOCK you

Source: The Financial Express Access to affordable pneumococcal conjugate vaccine (PCV) will become tougher after the Indian patent office granted a patent to US pharma major Pfizer for its PCV13 product, marketed as Prevnar13. Access to affordable pneumococcal conjugate vaccine … Continue reading

Posted in Indian Patent Office, Patent, Patent Opposition, Uncategorized, Vaccines | Leave a comment

India grants patent to Pfizer’s pneumonia vaccine despite opposition

Source: Money Control Pfizer application for patent was met with opposition from Indian vaccine maker Panacea Biotec and Medicines Sans Frontieres (MSF), a Paris-based international humanitarian-aid non-governmental organization on grounds that Pfizer is seek patent for mere addition of serotypes … Continue reading

Posted in Indian Patent Law, Patent Opposition, Patents, Uncategorized, Vaccines | Leave a comment

Amid opposition, India gives Pfizer the patent to exclusively sell vital pneumonia vaccine

Various groups believe the decision will make the shot less accessible to the poor. Source: Scroll India has granted Mumbai-based pharmaceutical company Pfizer Inc a patent for its pneumonia vaccine Prevenar 13, amid opposition from groups that say the decision … Continue reading

Posted in Indian Patent Office, Patent Opposition, Uncategorized, Vaccines | Leave a comment